Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
@article{171337,
author = {Pinninti Venkata Sai},
title = {Atorvastatin as an Antihyperlipidemic drug : A Comprehensive Review},
journal = {International Journal of Innovative Research in Technology},
year = {2024},
volume = {11},
number = {7},
pages = {3872-3873},
issn = {2349-6002},
url = {https://ijirt.org/article?manuscript=171337},
abstract = {Atorvastatin belongs to class of medications called HMG-CoA reductase inhibitors or statins. Atorvastatin is used as a first line drug for hyperlipidemia, a condition characterized by elevated levels of cholesterol in the blood. It works by inhibiting HMG-CoA reductase, an enzyme which is present in liver tissue that plays a key role in the production of cholesterol in the body. This review provides a good understanding of atorvastatin as an antihyperlipidemic drug.},
keywords = {Atorvastatin, Cholesterol, Lipoprotein, Triglycerides.},
month = {December},
}
Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.
Join NowNational Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024
Submit inquiry